Closed-loop brain neurofeedback on the left prefrontal cortex to lower stress-related heart responses in people with coronary heart disease and anxiety.
Official title: Closed-Loop Neurofeedback Targeting the Left Dorsolateral Prefrontal Cortex for Cardiac Autonomic Modulation in Coronary Artery Disease With Anxiety - A Randomized, Sham-Controlled Trial (HEART-SET-2)
Run by Shenyang Medical College · NCT07244484 · Data updated 2026-11-12
This trial will test whether closed‑loop fNIRS neurofeedback aimed at the left dorsolateral prefrontal cortex can lower heart rate during a cold‑pain stress test in adults with stable coronary heart disease and anxiety.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 56 (estimated) |
| Sponsor | Shenyang Medical College Academic / other |
| Locations | 1 site (Shenyang, Liaoning) |
| Status | Recruiting |
| Started | November 23, 2025 |
| Main results expected | May 23, 2026 |
| Study ends | May 30, 2026 |
| Registry record updated | April 22, 2026 |
| Trial ID | NCT07244484 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults over 18 with confirmed stable coronary heart disease, a DSM‑5 anxiety disorder, right‑handedness, resting heart rate 60–100 bpm, HAMA score ≥16 and HAMD‑17 score ≤17 who can attend site visits and tolerate fNIRS and cold‑pressor testing are ideal candidates.
✕Probably not a fit
Patients with unstable cardiac conditions (for example acute unstable angina, severe congestive heart failure NYHA class IV), atrial fibrillation, significant valvular disease, unstable blood pressure, or those unable to undergo fNIRS or cold‑pain testing are unlikely to receive benefit from this intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This exploratory interventional trial uses real‑time fNIRS-based closed‑loop neurofeedback to train left dorsolateral prefrontal cortex (DLPFC) activation in adults with stable coronary heart disease and comorbid anxiety. Participants receive either real left DLPFC neurofeedback or a sham control while undergoing standardized cold‑induced pain stress, and baseline‑corrected heart rate during the stress window is the primary physiological outcome. The study also measures participants' ability to volitionally upregulate left DLPFC activation, interhemispheric DLPFC synchronisation, and records adverse events during training and experimental sessions. Analyses will test whether changes in heart rate are associated with and partly mediated by changes in DLPFC activation or interhemispheric synchrony.
Why it matters
Potential benefit: If successful, this approach could reduce stress‑related heart rate surges and improve cardiac autonomic regulation in people with coronary heart disease and anxiety.
How similar studies have gone: Preliminary neurofeedback work in healthy and psychiatric samples has shown some ability to change prefrontal activity and autonomic markers, but closed‑loop fNIRS neurofeedback specifically targeted to left DLPFC in coronary heart disease with anxiety is largely novel and unproven.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age \>18 years, any sex. * Right-handed, with resting heart rate between 60 and 100 beats per minute. * Confirmed diagnosis of CHD, defined as at least one of the following: (i) positive stress test; (ii) documented myocardial infarction (MI) with electrocardiographic changes and concurrent elevation of creatine kinase MB isoenzyme or troponin; (iii) angiographically confirmed coronary atherosclerosis with ≥50% stenosis in at least one coronary artery. * Diagnosis of an anxiety disorder according to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5). * Hamilton Anxiety Rating Scale (HAMA) score ≥16 and 17-item Hamilton Depression Rating Scale (HAMD-17) score ≤17. Exclusion Criteria: * Acute unstable angina. * Severe congestive heart failure (New York Heart Association \[NYHA\] class IV). * Valvular heart disease. * History of atrial fibrillation. * Unstable blood pressure, defined as systolic blood pressure \>180 mmHg or \<90 mmHg. * Pregnancy. * History of unstable medical conditions, including cerebrovascular disease, dementia, hyperthyroidism, pulmonary disease, or malignancy. These are assessed through medical history, electronic health records, physical examination, and ECG findings. * High risk of suicide or homicide. * Presence of other psychiatric disorders, including psychotic disorders, bipolar disorder, or active substance use disorders. * Use of psychotropic medication within 1 month prior to enrolment, to avoid potential interference with haemodynamic measurements.
Where it's running
-
Second Affiliated Hospital of Shenyang Medical College
Shenyang, Liaoning, China Recruiting
Study contacts
- Principal investigator: Lin Tao, MM — Shenyang Medical College
- Study coordinator: Lin Tao, MM
- Email: 1939908868@qq.com
- Phone: 86-18802401698
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Closed-loop neurofeedback targeting the right prefrontal cortex to improve heart regulation in people with coronary heart disease and anxiety
This trial will try real-time fNIRS neurofeedback aimed at the right dorsolateral prefrontal cortex to lower sympathetic heart activity and improve heart rate variability in right-handed adults with stable coronary heart disease and DSM-5 anxiety.
-
Understanding anxiety, depression, and bipolar disorder over time in China
This study tests how anxiety, depressive, and bipolar symptoms change over three years to find patterns that help with earlier recognition and prediction in people aged 12–55.
-
See if personalized CBM-I can help anxious kids ages 10–17
Aimed at youth with Generalized, Separation, or Social Anxiety, the study tests a personalized cognitive bias modification for interpretation (CBM-I) to see if it reduces threat-focused thinking and anxiety.
-
Expectancy Focused Exposure for Anxiety Disorders
We test whether Expectancy Focused Exposure helps reduce anxiety symptoms and prevent fear from coming back better than Anxiety Focused Exposure in adults with anxiety disorders.
-
Does extra family income improve child mental health and brain biology in low-income families?
This study tests whether three years of extra income for parents can improve their child’s mental health and neuroimmune function.
-
Parent group program using the Unified Protocol for teens with autism and anxiety/depression
This trial tests a parent-guided adaptation of the Unified Protocol to help adolescents with autism and co-occurring anxiety or depression.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.